2028年までのアジア太平洋ヒト肝臓モデル市場予測 - 新型コロナウイルス感染症の影響とタイプ別(肝臓オルガノイド、肝臓オンチップ、2Dモデル、3Dバイオプリンティングなど)、アプリケーション別(創薬、教育など)の地域分析)、エンドユーザー(製薬企業、バイオテクノロジー企業、研究機関など)

TIPRE00026111 | Pages: 112 | Biotechnology | Nov 2021 | Type: Regional | Status: Published
APACヒト肝臓モデル市場は、2021年の33,191.56千米ドルから2028年までに76,341.40千米ドルに成長すると予想されています。 2021 年から 2028 年までに 12.6% の CAGR で成長すると推定されています。\\n\\n中国、日本、インド、韓国、オーストラリアは APAC の主要経済国です。創薬活動への注目の高まりにより、市場の成長が急拡大すると予想されます。新薬が臨床研究で試験される前に、動物モデルと二次元 (2D) in vitro モデルを使用して、薬力学と薬物動態の主相分析が実行されます。単一の薬が市場に出るまでには 1,215 年の歳月と 350 億米ドルがかかります。新薬や先進薬に対する需要の増加により、創薬と発見の全体的なペースが加速しています。その結果、新薬の発明と商品化のために多数の臨床研究が実施されています。市場投入後(フェーズ IV)でも、依然として毒性学的理由により多くの薬剤が中止されています。これらの離脱症状の約 1830% は肝毒性によるものであり、肝臓が薬物副作用 (ADR) の最も一般的な標的であることを示しています。肝臓は薬物代謝、体の恒常性、消化、有毒物質の排泄において重要な役割を果たしています。肝臓の場合、創薬のための最も単純なモデルは、薬物代謝酵素 (DME) または単離されたミトコンドリアを含むミクロソームなどの単離された細胞内画分です。高い感度と特異性を実現するには、細胞ベースのモデルで高次の薬物プロセス [すなわち、生体内変換、輸送動態、二次代謝産物形成、薬物相互作用 (DDI)] を再現する必要があります。ヒト肝臓モデルは、化合物や薬物の代謝と毒性を評価したり、癌研究や遺伝子研究における薬剤候補を評価したりするために使用されます。臨床試験の大幅な増加により、オルガノイド モデルを含む高度な医療技術の需要が高まり、APAC 市場の成長が促進されると予想されます。\\n\\nAPAC のバイオ医薬品業界は、2020 年に新型コロナウイルス感染症 (COVID-19) が発生した数か月間混乱に見舞われました。 。新型コロナウイルス感染症(COVID-19)のパンデミックにより、感染拡大を抑制するために課された制限により臨床試験が中断された。しかし、新型コロナウイルス感染症を治療する製品の需要が高まる中、インドと中国のバイオ医薬品および製薬会社は研究活動に引き続き注力した。たとえば、2020年2月、Vir Biotechnology(米国)はWuXi Biologics(中国)と提携して、新型コロナウイルス感染症を治療するためのヒトモノクローナル抗体を開発しました。この提携には臨床開発、製造、商業化が含まれており、WuXi Biologics は臨床開発のためのプロセスと製剤の開発、および初期生産を担当します。さらに、この地域の企業は、新型コロナウイルス感染症ワクチンの開発に集中するため、中核となる活動を保留している。たとえば、2020年3月、バイオテクノロジーCROのノボテック(オーストラリア)は、新型コロナウイルス感染症(COVID-19)の潜在的な治療法としてのパナフィックスの臨床試験でコミファーム・インターナショナル(韓国)と提携した。新型コロナウイルス感染症(COVID-19)の発生に対応して多くの国で最近課された制限は、進行中の臨床研究に影響を与えています。 \\n\\n新しい機能とテクノロジーを使用することで、ベンダーは新しい顧客を引き付け、新興市場での拠点を拡大できます。この要因は、アジア太平洋地域のヒト肝臓モデル市場を牽引する可能性があります。 APACヒト肝臓モデル市場は、予測期間中に良好なCAGRで成長すると予想されます。 \\n\\nAPAC ヒト肝臓モデル市場の収益と 2028 年までの予測 (千米ドル) \\n\\nAPAC ヒト肝臓モデル市場セグメンテーション \\nAPAC ヒト肝臓モデル市場のタイプ別\\n- 肝臓オルガノイド\\n- 肝臓オンチップ\\n- 2D モデル\\n- 3D バイオプリンティング\\n- その他\\nアプリケーション別のAPACヒト肝臓モデル市場\\n- 創薬\\n- 教育\\n- その他\\nエンドユーザー別のAPACヒト肝臓モデル市場\\n- 製薬およびバイオテクノロジー企業\\n- 研究機関 \\n- その他 \\nAPAC ヒト肝臓モデル市場、国別\\n- 日本 \\n- 中国\\n- インド\\n- 韓国 \\n- オーストラリア\\n- APAC のその他の地域\\nAPAC ヒト肝臓モデル市場 - 言及されている企業 \\n- BioIVT\\n- CELLINK\\n- CYFUSE BIOMEDICAL KK\\n- Emulate, Inc.\\n- InSphero\\n- Kerafast\\n- MIMETAS BV\\n- THERMO FISHER SCIENTIFIC INC.\\n\\ n
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Human Liver Models Market By Type
1.3.2 APAC Human Liver Models Market By Application
1.3.3 APAC Human Liver Models Market By End User
1.3.4 APAC Human Liver Models Market By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Human Liver Models Market Market Landscape
4.1 Overview
4.2 APAC PEST Analysis
4.3 Experts Opinion
5. APAC Human Liver Models Market Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Liver Diseases
5.1.2 Growing Focus on Developing Alternatives for Animal Testing Models
5.2 Market Restraints
5.2.1 High Costs of Liver Models
5.3 Market Opportunities
5.3.1 Increasing focus on Drug Discovery Activities
5.4 Future Trends
5.4.1 Technology Advancements in Organ Printing
5.1 Impact analysis
6. Human Liver Models Market APAC Analysis
6.1 APAC Human Liver Models Market Revenue Forecast and Analysis
7. APAC Human Liver Models Market Analysis By Type
7.1 Overview
7.2 APAC Human Liver Models Market Revenue Share, by Type (2021 and 2028)
7.3 Liver Organoids
7.3.1 Overview
7.3.2 Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.4 Liver-on-a-chip
7.4.1 Overview
7.4.2 Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.5 2D Models
7.5.1 Overview
7.5.2 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.6 3D Bioprinting
7.6.1 Overview
7.6.2 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.7 Others
7.7.1 Overview
7.7.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8. APAC Human Liver Models Market Analysis By Application
8.1 Overview
8.2 APAC Human Liver Models Market Share, by Application, 2021 and 2028, (%)
8.3 Educational
8.3.1 Overview
8.3.2 Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.4 Drug Discovery
8.4.1 Overview
8.4.2 Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.5 Other
8.5.1 Overview
8.5.2 Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9. APAC Human Liver Models Market Analysis By End User
9.1 Overview
9.2 APAC Human Liver Models Market Share, by End User, 2021 and 2028, (%)
9.3 Research Institutes
9.3.1 Overview
9.3.2 Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.4 Pharmaceutical and Biotechnology Companies
9.4.1 Overview
9.4.2 Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.5 Others
9.5.1 Overview
9.5.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
10. APAC Human Liver Models Market Country Analysis
10.1 APAC: Human Liver Models Market
10.1.1 Overview
10.1.2 APAC: Human Liver Models Market, by Country, 2021 & 2028 (%)
10.1.2.1 China: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.1.1 China: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.1.2 China: Human Liver Models Market, by Type, 20192028 (USD Thousand)
10.1.2.1.3 China: Human Liver Models Market, By Application, 20192028 (USD Thousand)
10.1.2.1.4 China: Human Liver Models Market, by End User, 20192028 (USD Thousand)
10.1.2.2 Japan: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.2.1 Japan: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.2.2 Japan: Human Liver Models Market, by Type, 20192028 (USD Thousand)
10.1.2.2.3 Japan: Human Liver Models Market, By Application, 20192028 (USD Thousand)
10.1.2.2.4 Japan: Human Liver Models Market, by End User, 20192028 (USD Thousand)
10.1.2.3 India: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.3.1 India: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.3.2 India: Human Liver Models Market, by Type, 20192028 (USD Thousand)
10.1.2.3.3 India: Human Liver Models Market, By Application, 20192028 (USD Thousand)
10.1.2.3.4 India: Human Liver Models Market, by End User, 20192028 (USD Thousand)
10.1.2.4 Australia: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.4.1 Australia: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.4.2 Australia: Human Liver Models Market, by Type, 20192028 (USD Thousand)
10.1.2.4.3 Australia: Human Liver Models Market, By Application, 20192028 (USD Thousand)
10.1.2.4.4 Australia: Human Liver Models Market, by End User, 20192028 (USD Thousand)
10.1.2.5 South Korea: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.5.1 South Korea: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.5.2 South Korea: Human Liver Models Market, by Type, 20192028 (USD Thousand)
10.1.2.5.3 South Korea: Human Liver Models Market, By Application, 20192028 (USD Thousand)
10.1.2.5.4 South Korea: Human Liver Models Market, by End User, 20192028 (USD Thousand)
10.1.2.6 Rest of APAC: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.6.1 Rest of APAC: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
10.1.2.6.2 Rest of APAC: Human Liver Models Market, by Type, 20192028 (USD Thousand)
10.1.2.6.3 Rest of APAC: Human Liver Models Market, By Application, 20192028 (USD Thousand)
10.1.2.6.4 Rest of APAC: Human Liver Models Market, by End User, 20192028 (USD Thousand)
11. Impact Of COVID-19 Pandemic on APAC Human Liver Models Market
11.1 APAC: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Emulate, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 CYFUSE BIOMEDICAL K.K.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 MIMETAS BV
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 InSphero
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 BioIVT
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 CELLINK
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Kerafast
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms


LIST OF TABLES
Table 1. APAC Human Liver Models Market, Revenue and Forecast, 20192028 (US$ Thousand)
Table 2. China: Human Liver Models Market, by Type Revenue and Forecast to 2028 (USD Thousand)
Table 3. China: Human Liver Models Market, By Application Revenue and Forecast to 2028 (USD Thousand)
Table 4. China: Human Liver Models Market, by End User Revenue and Forecast to 2028 (USD Thousand)
Table 5. Japan: Human Liver Models Market, by Type Revenue and Forecast to 2028 (USD Thousand)
Table 6. Japan: Human Liver Models Market, By Application Revenue and Forecast to 2028 (USD Thousand)
Table 7. Japan: Human Liver Models Market, by End User Revenue and Forecast to 2028 (USD Thousand)
Table 8. India: Human Liver Models Market, by Type Revenue and Forecast to 2028 (USD Thousand)
Table 9. India: Human Liver Models Market, By Application Revenue and Forecast to 2028 (USD Thousand)
Table 10. India: Human Liver Models Market, by End User Revenue and Forecast to 2028 (USD Thousand)
Table 11. Australia: Human Liver Models Market, by Type Revenue and Forecast to 2028 (USD Thousand)
Table 12. Australia: Human Liver Models Market, By Application Revenue and Forecast to 2028 (USD Thousand)
Table 13. Australia: Human Liver Models Market, by End User Revenue and Forecast to 2028 (USD Thousand)
Table 14. South Korea: Human Liver Models Market, by Type Revenue and Forecast to 2028 (USD Thousand)
Table 15. South Korea: Human Liver Models Market, By Application Revenue and Forecast to 2028 (USD Thousand)
Table 16. South Korea: Human Liver Models Market, by End User Revenue and Forecast to 2028 (USD Thousand)
Table 17. Rest of APAC: Human Liver Models Market, by Type Revenue and Forecast to 2028 (USD Thousand)
Table 18. Rest of APAC: Human Liver Models Market, By Application Revenue and Forecast to 2028 (USD Thousand)
Table 19. Rest of APAC: Human Liver Models Market, by End User Revenue and Forecast to 2028 (USD Thousand)
Table 20. Organic Developments Done by Companies
Table 21. Inorganic Developments Done by Companies
Table 22. Glossary of Terms


LIST OF FIGURES
Figure 1. APAC Human Liver Models Market Segmentation
Figure 2. APAC Human Liver Models Market Segmentation, By Country
Figure 3. APAC Human Liver Models Market Overview
Figure 4. Liver Organoids Held the Largest Share in 2020
Figure 5. India to Show Significant Growth During Forecast Period
Figure 6. APAC PEST Analysis
Figure 7. APAC Human Liver Models Market Impact Analysis of Drivers and Restraints
Figure 8. APAC Human Liver Models Market Revenue Forecast and Analysis
Figure 9. APAC Human Liver Models Market Revenue Share, by Type (2021 and 2028)
Figure 10. APAC Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 11. APAC Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 12. APAC 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 13. APAC 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 14. APAC Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 15. APAC Human Liver Models Market Share, by Application, 2021 and 2028 (%)
Figure 16. APAC Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 17. APAC Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 18. APAC Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 19. APAC Human Liver Models Market Share, by End User, 2021 and 2028 (%)
Figure 20. APAC Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 21. APAC Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 22. APAC Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 23. APAC: Human Liver Models Market, by Key Country Revenue (2021) (USD Thousand)
Figure 24. APAC: Human Liver Models Market, by Country, 2021 & 2028 (%)
Figure 25. China: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
Figure 26. Japan: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
Figure 27. India: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
Figure 28. Australia: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
Figure 29. South Korea: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
Figure 30. Rest of APAC: Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)
Figure 31. Impact of COVID-19 Pandemic in APAC Country Markets

1. BioIVT
2. CELLINK
3. CYFUSE BIOMEDICAL K.K.
4. Emulate, Inc.
5. InSphero
6. Kerafast
7. MIMETAS BV
8. THERMO FISHER SCIENTIFIC INC.

- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC human liver models market. - Highlights key business priorities in order to assist companies to realign their business strategies - The key findings and recommendations highlight crucial progressive industry trends in the APAC human liver models market, thereby allowing players across the value chain to develop effective long-term strategies - Develop/modify business expansion plans by using substantial growth offering developed and emerging markets - Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the human liver models market, as well as those hindering it - Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000